Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research into the early detection of ovarian cancer by the Ahmed group, receives a boost thanks to a gift of £43,000 from the Dianne Oxberry Trust.

© Dr Siobhan Ferguson & Ian Hindle (Dianne Oxberry Trust), Prof Ahmed Ahmed, Abdulkhaliq Alsaadi & Mara Artibani (Weatherall Institute of Molecular Medicine, NDWRH, Oxford University)

Research into the early detection of ovarian cancer will receive a boost, thanks to a gift of £43,000 from the Dianne Oxberry Trust. The donation will support doctoral candidate Abdulkhaliq Alsaadi in this research by covering the stipend and other costs associated with his final year of study, including research consumables.

More than 250,000 women around the world are diagnosed with ovarian cancer every year, with almost half dying from the disease. This makes ovarian cancer the most common cause of death from a gynaecological malignancy. Late diagnosis a key contributing factor.

At Oxford, a concerted effort is being made to better understand the origins of the disease. Led by Professor Ahmed Ahmed, Professor of Gynaecological Oncology in the Nuffield Department of Women’s and Reproductive Health, researchers are utilising cutting-edge methodologies to classify the cells in the fallopian tube – thought to be the organ from which most ovarian cancers develop. It is hoped that this will lead to the discovery of new biomarkers that could be used for pre-cancer screening.

Working under Professor Ahmed’s supervision, Abdulkhaliq is developing a system for growing fallopian tub­e organoids (mini-fallopian tubes) in the lab. These organoids can be used to investigate the different cell types within fallopian tubes, and model how ovarian cancer starts. The Dianne Oxberry Trust’s generosity will enable Abdulkhaliq to continue this important work for a further year. 

Professor Ahmed says: ‘This very generous donation from the Dianne Oxberry Trust will support our endeavours to better understand how ovarian cancer begins. Early detection is crucial to surviving this terrible disease, and this funding from the Dianne Oxberry Trust gets us one step closer to reaching that goal.’

The Dianne Oxberry Trust was set up in the memory of BBC presenter Dianne Oxberry, who died from ovarian cancer in January 2019, at the age of 51. Established by her husband Ian Hindle, the trust supports those affected by ovarian cancer through the provision of grants, information and advice.

‘The work Professor Ahmed and his team are doing is incredible,’ says Ian. ‘Hopefully with our donation we are going to make a difference.’

Dr Siobhan Ferguson, Trustee of the Dianne Oxberry Trust, adds: ‘Knowing what we know about what happened to Dianne, how short her journey was, the emphasis on early diagnosis is so important. You really get a sense that the team are breaking ground and that they will perhaps, within our lifetime, be able to spot women much earlier in the disease process.’

 

 

Latest news

Unequal access to early pregnancy scans delays detection of serious conditions

Early screening resulted in earlier detection for 40% of anomalies, including heart and limb issues. Researchers from the University of Oxford, together with colleagues from the NHS and other partners, have published the first population-level study linking first-trimester ultrasound practice with early detection rates for serious congenital anomalies.

Early Diagnosis Saves Lives: New Study Highlights Critical Window for Postpartum Haemorrhage Care

A new international study co-led by Professor Arri Coomarasamy of the University of Birmingham and the Nuffield Department of Women’s and Reproductive Health, University of Oxford, has shown that diagnosing postpartum haemorrhage (PPH) within the first 90 minutes after childbirth can be crucial in preventing maternal deaths.

From Oxford to Empowerment: Why Fertility Awareness Matters

We’re delighted to share an inspiring piece by Maryam Rahbar, a former MSc in Clinical Embryology and DPhil student in Women’s & Reproductive Health at Oxford. Drawing on her academic journey and passion for translating science into empowerment, Maryam explores the science and significance of fertility awareness and preservation. Her reflections remind us that informed choice, grounded in knowledge, not fear, is one of the most powerful forms of reproductive autonomy.

Oxford researchers awarded funding to pioneer ovarian cancer vaccine development

Ovarian cancer remains a devastating global health challenge: each year, over 300,000 women are diagnosed, and nearly 200,000 lives are lost, largely because the disease is detected at a late stage. Women carrying inherited genetic changes face a significantly elevated lifetime risk, over 40%, and current preventive strategies often require invasive surgery that compromises fertility. These limitations underscore an urgent need for non-surgical preventive options, and vaccines could offer a groundbreaking solution.

Upcoming OxTalks

Our Research Groups